Chemical Compound Review:
AC1L1GVU 10-(4-aminobutyl)-19-[(2- amino-3-phenyl...
Synonyms:
- A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study. Spahr, L., Giostra, E., Frossard, J.L., Morard, I., Mentha, G., Hadengue, A. Am. J. Gastroenterol. (2007)
- Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Junquera, F., Saperas, E., Videla, S., Feu, F., Vilaseca, J., Armengol, J.R., Bordas, J.M., Piqué, J.M., Malagelada, J.R. Am. J. Gastroenterol. (2007)
- Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas. Plöckinger, U., Albrecht, S., Mawrin, C., Saeger, W., Buchfelder, M., Petersenn, S., Schulz, S. J. Clin. Endocrinol. Metab. (2008)
- Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment. Fougner, S.L., Bollerslev, J., Latif, F., Hald, J.K., Lund, T., Ramm-Pettersen, J., Berg, J.P. J. Clin. Endocrinol. Metab. (2008)
- The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats. Mejias, M., Garcia-Pras, E., Tiani, C., Bosch, J., Fernandez, M. J. Cell. Mol. Med. (2008)
- Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial. Vorobioff, J.D., Ferretti, S.E., Zangroniz, P., Gamen, M., Picabea, E., Bessone, F.O., Reggiardo, V., Diez, A.R., Tanno, M., Cuesta, C., Tanno, H.E. Am. J. Gastroenterol. (2007)
- Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. Lesche, S., Lehmann, D., Nagel, F., Schmid, H.A., Schulz, S. J. Clin. Endocrinol. Metab. (2009)